Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with Neurofibromatosis Type 1 By Ogkologos - July 1, 2025 539 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the KOMET study Source RELATED ARTICLESMORE FROM AUTHOR Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours Rare Disease Day 2026: Advancing equity for people living with rare cancers in Europe EMA Recommends Extension of Therapeutic Indications for Ponatinib MOST POPULAR New Cancer Model Shows Promise in Predicting If Treatment Will Shrink... July 28, 2022 Shannen Doherty Reveals She Has Stage IV Breast Cancer February 5, 2020 Corgi Named Dolly Didn’t Win At Westminster, But Is A Champion... February 12, 2020 The Potential of AI to Improve Cancer Care is Only Going... October 16, 2023 Load more HOT NEWS 细针穿刺活检：如何准备和会发生什么 New Treatment Combinations Slow Progression of Prostate Cancer and Stomach and... UK health inequalities: 20,000 more cancer cases a year in the... Weekend in New England
